Karl‐Walter Sykora

5.5k citations

45 papers · 2.2k indexed · h-index 20

Hematology top 1%
- Hematopoietic Stem Cell Transplantation 16
Immunology top 5%
Public Health, Environmental and Occupational Health top 5%
- Acute Lymphoblastic Leukemia research 12
Oncology top 5%
- Neutropenia and Cancer Infections 6
- Polyomavirus and related diseases 5
Transplantation top 5%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 6
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 5
Genetics
- Blood disorders and treatments 5
Physiology
- Lysosomal Storage Disorders Research 5

Co-authors: Karl Welte Gabriele Hintzen A. Kemper Katrin Beul Reinhilde Jacobs Reinhold E. Schmidt Georg M. N. Behrens Martin Schrappe
Cited by: Hematology Immunology Public Health, Environmental and Occupational Health
Journals: Journal of Clinical Oncology (3 papers)Blood (7 papers)Annals of Oncology (1 paper)
Partner nations: Germany United Kingdom Netherlands

In The Last Decade

Karl‐Walter Sykora

44 papers receiving 2.1k citations

Peers

Countries citing papers authored by Karl‐Walter Sykora

Since Specialization

Citations

This map shows the geographic impact of Karl‐Walter Sykora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Walter Sykora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Walter Sykora more than expected).

Fields of papers citing papers by Karl‐Walter Sykora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl‐Walter Sykora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Walter Sykora. The network helps show where Karl‐Walter Sykora may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karl‐Walter Sykora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karl‐Walter Sykora Line = papers co-authored together Karl‐Walter Sykora links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation Drug Metabolism and Pharmacokinetics ·Xieran Li,Krzysztof Kałwak,Rita Beier,Jochen Kehne,Ann-Kristin Möller,Joachim Baumgart,Dietrich W. Beelen,Ralf A. Hilger,Ajay Vora,Karl‐Walter Sykora	2023	0
2	Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age Bone Marrow Transplantation ·Bianca Borchert‐Mörlins,Nima Memaran,Martin G. Sauer,Britta Maecker‐Kolhoff,Karl‐Walter Sykora,Ricarda Blöte,Elena Bauer,Bernhard M. W. Schmidt,Anette Melk,Rita Beier	2018	20
3	Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT American Journal of Transplantation ·Grzegorz Basak,W Wiktor-Jędrzejczak,Myriam Labopin,Hélène Schoemans,Per Ljungman,Guido Kobbe,Yves Béguin,Peter Lang,Christian Koenecke,Karl‐Walter Sykora,Liane te Boome,Anja van Biezen,Steffie van der Werf,Mohamad Mohty,T. de Witte,Judith Marsh,Peter Dreger,Nicolaus Kröger,Rafael F. Duarte,Tapani Ruutu	2015	14
4	Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation Child s Nervous System ·Michèle Aumüller,Karl‐Walter Sykora,Christian Hartmann,Elvis J. Hermann,Joachim K. Krauss	2014	2
5	Patient, Virus, and Treatment-Related Risk Factors in Pediatric Adenovirus Infection after Stem Cell Transplantation: Results of a Routine Monitoring Program Biology of Blood and Marrow Transplantation ·Martin Mynarek,Tina Ganzenmueller,Annika Mueller-Heine,Christopher Mielke,Andrea Gonnermann,Rita Beier,Martin G. Sauer,Britta Eiz‐Vesper,Ute Kohstall,Karl‐Walter Sykora,Albert Heim,Britta Maecker‐Kolhoff	2013	70
6	Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure Orphanet Journal of Rare Diseases ·Minke H. de Ru,Jaap Jan Boelens,Anibh M. Das,Simon Jones,Johanna H. van der Lee,Nizar Mahlaoui,Eugen Mengel,Martin Offringa,Anne O’Meara,Rossella Parini,Attilio Rovelli,Karl‐Walter Sykora,Vassili Valayannopoulos,Ashok Vellodi,Robert Wynn,Frits A. Wijburg	2011	177
7	Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group Journal of Clinical Oncology ·Peter Bader,Hermann Kreyenberg,Günter Henze,Cornelia Eckert,Miriam Reising,André Willasch,Andrea Barth,Arndt Borkhardt,Christina Peters,Rupert Handgretinger,Karl‐Walter Sykora,Wolfgang Holter,H. Kabisch,Thomas Klingebiel,Arend von Stackelberg	2008	252
8	An Adenovirus Type F41 Outbreak in a Pediatric Bone Marrow Transplant Unit The Pediatric Infectious Disease Journal ·Frauke Mattner,Karl‐Walter Sykora,Barbara Meissner,Albert Heim	2008	32
9	Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem‐cell transplant recipients. The trough level is not enough Pediatric Transplantation ·André Schrauder,Sheima T. Saleh,Karl‐Walter Sykora,Haley Hoy,Karl Welte,Joachim Boos,Georg Hempel,Lorenz Grigull	2008	16
10	Lethal graft‐versus‐host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA‐identical sibling Pediatric Blood & Cancer ·Georg Bohn,Matthias Hardtke‐Wolenski,Cornelia Zeidler,Britta Maecker,Martin G. Sauer,Karl‐Walter Sykora,Lorenz Grigull,Karl Welte,Christoph Klein	2008	5
11	Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia Bone Marrow Transplantation ·Barbara Meissner,Arndt Borkhardt,Dagmar Dilloo,D. Fuchs,W Friedrich,Rupert Handgretinger,Christina Peters,André Schrauder,Friedhelm R. Schuster,Josef Vormoor,Britta Maecker,Karl‐Walter Sykora,F Zintl,Karl Welte,Martin G. Sauer	2007	24
12	Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study Developmental Medicine & Child Neurology ·Thomas Lücke,Anibh M. Das,Hans Hartmann,Karl‐Walter Sykora,Frank Donnerstag,Gerhard Schmid‐Ott,Lorenz Grigull	2007	21
13	Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure Bone Marrow Transplantation ·Jaap Jan Boelens,Robert Wynn,A. O’Meara,Paul Veys,Y. Bertrand,G Souillet,J. E. Wraith,Alain Fischer,Marina Cavazzana,Karl‐Walter Sykora,Petr Sedláček,Attilio Rovelli,Cuno S.P.M. Uiterwaal,N. M. Wulffraat	2007	152
14	G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis Supportive Care in Cancer ·Lorenz Grigull,Nicole Pulver,Lilia Goudeva,Karl‐Walter Sykora,Christin Linderkamp,Andreas Beilken,Kathrin Seidemann,Hansjörg Schmid,Karl Welte,Hans‐Gert Heuft	2006	45
15	Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler) Bone Marrow Transplantation ·Lorenz Grigull,Andreas Beilken,Martin Schrappe,Anibh M. Das,Thomas Luecke,Annette Sander,Martin Stanulla,Klaus Rehe,Martin G. Sauer,Hansjörg Schmid,Karl Welte,Zoltán Lukács,Andreas Gal,Karl‐Walter Sykora	2004	22
16	Efficacy and Safety of G-CSF Mobilized Granulocyte Transfusions in Four Neutropenic Children with Sepsis and Invasive Fungal Infection Infection ·Lorenz Grigull,André Schrauder,Angela Schmitt‐Thomssen,Karl‐Walter Sykora,Karl Welte	2002	13
17	CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells European Journal of Immunology ·Reinhilde Jacobs,Gabriele Hintzen,A. Kemper,Katrin Beul,Sandra Kempf,Georg M. N. Behrens,Karl‐Walter Sykora,Reinhold E. Schmidt	2001	368
18	Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters European Journal of Pediatrics ·C. Wermes,M. Depka Prondzinski,Ralph Lichtinghagen,M. Barthels,Karl Welte,Karl‐Walter Sykora	1999	84
19	Absence of IL‐6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL‐6 receptors by Epstein‐Barr virus in vitro British Journal of Haematology ·Jörg Tomeczkowski,Udo zur Stadt,Alfred Reiter,Karl Welte,Karl‐Walter Sykora	1997	6
20	Absence of G‐CSF receptors and absent response to G‐CSF in childhood Burkitt's lymphoma and B‐ALL cells British Journal of Haematology ·Jörg Tomeczkowski,Elif Yakisan,Britta Wieland,Alfred Reiter,Karl Welte,Karl‐Walter Sykora	1995	16

About Karl‐Walter Sykora

Karl‐Walter Sykora is a scholar working on Hematology, Transplantation and Oncology, having authored 45 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Lymphoblastic Leukemia research (12 papers), Neutropenia and Cancer Infections (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Blood disorders and treatments (5 papers), Lysosomal Storage Disorders Research (5 papers) and Polyomavirus and related diseases (5 papers). The work is most often cited by research in Hematology (755 citations), Immunology (580 citations) and Public Health, Environmental and Occupational Health (574 citations). Karl‐Walter Sykora has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Karl Welte, Gabriele Hintzen, A. Kemper, Katrin Beul, Reinhilde Jacobs, Reinhold E. Schmidt, Georg M. N. Behrens, Martin Schrappe, Alfred Reiter and Rupert Handgretinger. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact